← Back to All Filings

Edwards Lifesciences CVP of Strategy Announces Future Retirement

Medium SignificanceAugust 28, 2026 at 4:37:14 PM EDT

Edwards Lifesciences Corp

$EW8-KCIK: 0001099800

Subscribe to track EW

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Edwards Lifesciences ($EW) announced that Donald E. Bobo, Jr., Corporate Vice President, Strategy and Corporate Development, has given notice of his decision to retire from the company by mid-year 2027. A successor search will begin promptly, with a transition expected during 2027. Mr. Bobo is also expected to remain as a consultant through the end of 2027.

Comprehensive Analysis

On August 25, 2026, Edwards Lifesciences Corp. disclosed the planned retirement of a key executive. Donald E. Bobo, Jr., the Corporate Vice President of Strategy and Corporate Development, has announced his intention to retire by the middle of 2027.

The company has initiated a search for his successor to ensure a smooth transition of duties throughout 2027. Following his retirement, Mr. Bobo is expected to continue with the company in a consulting capacity until the end of 2027. This long-term, planned departure in a critical strategic role allows the company ample time to manage the leadership change, mitigating potential disruption.

Topics:#EdwardsLifesciences#ExecutiveMove#Retirement

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.